Insider Trading activities of Forest Laboratories Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Forest Laboratories Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Forest Laboratories Inc since year 2005. Table 2 shows the detailed insider transactions of Forest Laboratories Inc since 2005. The reporting company's ticker symbol is FRX. The reporting company's CIK number is 38074.
The total value of stock buying since 2005 is $142,440,220.
The total value of stock sales since 2005 is $442,283,755.
The total value of stock option exercises since 2005 is $137,656,414.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Forest Laboratories Inc (FRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2013-08 0 $0 13,104 $563,431 0 $0
2013-03 0 $0 12,743 $477,064 9,621 $262,027
2013-02 0 $0 26,350 $943,303 26,350 $712,978
2013-01 0 $0 7,000 $255,969 0 $0
2012-12 0 $0 15,942 $582,249 0 $0
2012-09 393,076 $13,604,755 13,561 $481,184 0 $0
2012-08 3,707,243 $127,385,577 1,500 $49,150 0 $0
2012-04 0 $0 8,390 $292,397 0 $0
2012-03 0 $0 561 $18,173 0 $0
2012-01 0 $0 41,848 $1,342,986 0 $0
2011-12 0 $0 38,898 $1,124,536 0 $0
2011-06 0 $0 5,621 $206,627 5,621 $158,652
2011-05 0 $0 3,000 $104,162 0 $0
2011-03 0 $0 7,000 $225,224 0 $0
2010-12 0 $0 3,888 $129,007 0 $0
2010-11 0 $0 11,000 $355,340 0 $0
2010-08 0 $0 17,000 $479,434 16,000 $394,752
2010-07 0 $0 1,000 $28,456 0 $0
2010-03 0 $0 0 $0 8,000 $197,376
2009-12 0 $0 0 $0 1,200,000 $15,777,600
2009-06 0 $0 0 $0 16,000 $196,624
2009-05 0 $0 0 $0 8,000 $98,320
2008-12 0 $0 0 $0 600,000 $7,251,600
2008-08 0 $0 12,500 $474,864 20,000 $195,300
2008-07 0 $0 2,215 $78,457 8,000 $78,120
2008-05 0 $0 62,000 $2,212,098 0 $0
2008-02 0 $0 0 $0 17,000 $130,679
2007-06 0 $0 6,700 $325,050 6,700 $37,761
2007-04 0 $0 9,300 $504,618 25,300 $142,590
2007-03 0 $0 10,500 $537,432 10,500 $190,221
2007-02 0 $0 4,905,235 $258,573,095 1,420,014 $28,058,116
2006-12 0 $0 337,000 $16,669,031 282,000 $3,408,252
2006-11 0 $0 2,986,034 $141,112,286 3,009,869 $76,987,651
2006-08 0 $0 70,140 $3,314,184 70,140 $922,200
2006-07 33,000 $1,449,888 24,979 $1,146,536 0 $0
2006-05 0 $0 95,281 $3,705,636 71,260 $1,238,828
2006-04 0 $0 0 $0 4,740 $99,947
2006-03 0 $0 20,000 $901,850 20,000 $153,740
2006-02 0 $0 19,840 $934,364 0 $0
2006-01 0 $0 94,728 $4,135,562 76,332 $963,080

Table 2. Detailed insider stock purchases, sales, and option exercises of Forest Laboratories Inc insiders (FRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-08-26 Olanoff Lawrence S (Director) Sale 1,104 42.96 47,431
2013-08-21 Francis Perier I Jr (EVP Finance & Admin. & CFO) Sale 12,000 43.00 516,000
2013-03-07 Basgoz Nesli (Director) Sale 12,200 37.47 457,097
2013-03-07 Basgoz Nesli (Director) Option Ex 9,621 27.24 262,027
2013-03-04 Olanoff Lawrence S (Director) Sale 543 36.77 19,967
2013-02-06 Meury William (SVP - Marketing) Sale 26,350 35.80 943,303
2013-02-06 Meury William (SVP - Marketing) Option Ex 26,350 27.06 712,978
2013-01-18 Weinstein Herschel S (SVP General Counsel) Sale 7,000 36.57 255,969
2012-12-10 Francis Perier I Jr (EVP Finance & Admin. & CFO) Sale 15,942 36.52 582,249
2012-09-13 Icahn Carl C Buy 130,232 34.57 4,502,120
2012-09-12 Icahn Carl C Buy 245,424 34.63 8,499,033
2012-09-06 Taglietti Marco (Sr.VP-R&D & Chief Medical Off.) Sale 13,000 35.51 461,604
2012-09-05 Olanoff Lawrence S (Director) Sale 561 34.90 19,580
2012-09-05 Icahn Carl C Buy 561 34.65 19,438
2012-09-04 Icahn Carl C Buy 16,859 34.65 584,164
2012-08-31 Icahn Carl C Buy 6,274 34.65 217,394
2012-08-30 Icahn Carl C Buy 63,715 34.63 2,206,450
2012-08-29 Icahn Carl C Buy 130,728 34.65 4,529,725
2012-08-28 Icahn Carl C Buy 4,052 34.64 140,361
2012-08-27 Icahn Carl C Buy 196,626 34.65 6,813,090
2012-08-24 Icahn Carl C Buy 152,442 34.64 5,280,590
2012-08-23 Icahn Carl C Buy 562,777 34.59 19,466,456
2012-08-22 Icahn Carl C Buy 628,618 34.53 21,706,179
2012-08-21 Icahn Carl C Buy 732,460 34.35 25,160,001
2012-08-20 Icahn Carl C Buy 371,551 34.14 12,684,751
2012-08-17 Icahn Carl C Buy 858,000 34.01 29,180,580
2012-08-03 Lynch Jerome (SVP-Sales) Sale 1,500 32.77 49,150
2012-04-18 Salans Lester B (Director) Sale 2,390 34.30 81,977
2012-04-17 Weinstein Herschel S (SVP General Counsel) Sale 6,000 35.07 210,420
2012-03-07 Olanoff Lawrence S (Director) Sale 561 32.39 18,173
2012-01-18 Meury William (SVP - Marketing) Sale 41,848 32.09 1,342,986
2011-12-15 Lynch Jerome (SVP-Sales) Sale 14,000 28.80 403,200
2011-12-14 Francis Perier I Jr (EVP Finance & Admin. & CFO) Sale 10,000 28.55 285,540
2011-12-13 Hochberg Elaine (EVP & CCO) Sale 14,898 29.25 435,796
2011-06-08 Zimetbaum Peter J. (Director) Sale 5,621 36.76 206,627
2011-06-08 Zimetbaum Peter J. (Director) Option Ex 5,621 28.22 158,652
2011-05-23 Taglietti Marco (Sr.VP-R&D & Chief Medical Off.) Sale 3,000 34.72 104,162
2011-03-10 Weinstein Herschel S (VP General Counsel) Sale 7,000 32.18 225,224
2010-12-16 Candee William J Iii (Director) Sale 3,888 33.18 129,007
2010-11-24 Candee William J Iii (Director) Sale 8,000 32.15 257,192
2010-11-18 Taglietti Marco (Exec. VP-Chief Medical Officer) Sale 3,000 32.72 98,148
2010-08-23 Salans Lester B (Director) Sale 1,000 27.83 27,826
2010-08-09 Candee William J Iii (Director) Sale 8,000 28.45 227,608
2010-08-09 Candee William J Iii (Director) Option Ex 8,000 24.67 197,376
2010-08-06 Cohan George S (Director) Sale 8,000 28.00 224,000
2010-08-06 Cohan George S (Director) Option Ex 8,000 24.67 197,376
2010-07-22 Basgoz Nesli (Director) Sale 1,000 28.46 28,456
2010-03-11 Goldwasser Dan L (Director) Option Ex 8,000 24.67 197,376
2009-12-11 Solomon Howard (Chairman and CEO) Option Ex 1,200,000 13.15 15,777,600
2009-06-16 Candee William J Iii (Director) Option Ex 8,000 12.29 98,312
2009-06-10 Cohan George S (Director) Option Ex 8,000 12.29 98,312
2009-05-26 Goldwasser Dan L (Director) Option Ex 8,000 12.29 98,320
2008-12-15 Solomon Howard (Chairman and CEO) Option Ex 600,000 12.09 7,251,600
2008-08-15 Candee William J Iii (Director) Sale 250 38.59 9,648
2008-08-14 Salans Lester B (Director) Sale 8,000 37.86 302,896
2008-08-14 Salans Lester B (Director) Option Ex 8,000 9.76 78,120
2008-08-08 Candee William J Iii (Director) Sale 4,250 38.19 162,320
2008-08-08 Candee William J Iii (Director) Option Ex 4,000 9.76 39,060
2008-08-01 Cohan George S (Director) Option Ex 8,000 9.76 78,120
2008-07-23 Goldwasser Dan L (Director) Sale 2,215 35.42 78,457
2008-07-23 Goldwasser Dan L (Director) Option Ex 8,000 9.76 78,120
2008-05-30 Hochberg Elaine (SVP Marketing) Sale 62,000 35.68 2,212,098
2008-02-13 Salans Lester B (Director) Option Ex 17,000 7.69 130,679
2007-06-14 Goldwasser Dan L (Director) Sale 6,700 48.52 325,050
2007-06-14 Goldwasser Dan L (Director) Option Ex 6,700 5.64 37,761
2007-04-27 Goldwasser Dan L (Director) Sale 9,300 54.26 504,618
2007-04-27 Goldwasser Dan L (Director) Option Ex 9,300 5.64 52,414
2007-04-26 Cohan George S (Director) Option Ex 16,000 5.64 90,176
2007-03-16 Salans Lester B (Director) Sale 7,000 50.97 356,762
2007-03-16 Salans Lester B (Director) Option Ex 7,000 7.69 53,809
2007-03-07 Basgoz Nesli (Director) Sale 3,500 51.62 180,670
2007-03-07 Basgoz Nesli (Director) Option Ex 3,500 38.98 136,412
2007-02-21 Prehn Mary E (VP Licensing) Sale 49,879 54.46 2,716,410
2007-02-21 Prehn Mary E (VP Licensing) Option Ex 49,879 42.33 2,111,228
2007-02-16 Triano Charles E (VP Investor Relations) Sale 70,129 54.18 3,799,799
2007-02-16 Triano Charles E (VP Investor Relations) Option Ex 70,129 40.45 2,836,437
2007-02-14 Gergel Ivan (SVP Scientific Affairs) Sale 32,250 53.45 1,723,859
2007-02-14 Gergel Ivan (SVP Scientific Affairs) Option Ex 32,250 38.87 1,253,557
2007-02-14 Hochberg Elaine (SVP Marketing) Sale 157,396 53.57 8,431,074
2007-02-14 Hochberg Elaine (SVP Marketing) Option Ex 160,384 23.30 3,736,947
2007-02-13 Prehn Mary E (VP Licensing) Option Ex 7,241 31.28 226,469
2007-02-13 Goodman Kenneth E (Director) Sale 295,581 53.19 15,721,953
2007-02-13 Goodman Kenneth E (Director) Option Ex 300,131 44.88 13,468,678
2007-02-12 Solomon Howard (Chairman and CEO) Sale 4,300,000 52.60 226,180,000
2007-02-12 Solomon Howard (Chairman and CEO) Option Ex 800,000 5.53 4,424,800
2006-12-04 Stafford Raymond (EVP - Global Marketing) Sale 337,000 49.46 16,669,031
2006-12-04 Stafford Raymond (EVP - Global Marketing) Option Ex 282,000 12.09 3,408,252
2006-11-21 Candee William J Iii (Secretary) Sale 10,000 49.47 494,680
2006-11-21 Candee William J Iii (Secretary) Option Ex 10,000 7.70 77,010
2006-11-02 Goodman Kenneth E (Director) Sale 2,976,034 47.25 140,617,606
2006-11-02 Goodman Kenneth E (Director) Option Ex 2,999,869 25.64 76,910,641
2006-08-10 Prehn Mary E (Vice President-Licensing) Sale 46,760 47.25 2,209,456
2006-08-10 Prehn Mary E (Vice President-Licensing) Option Ex 46,760 13.15 614,800
2006-07-26 Prehn Mary E (Vice President-Licensing) Sale 24,979 45.90 1,146,536
2006-07-20 Cohan George S (Director) Buy 22,000 43.94 966,592
2006-05-23 Cohan George S (Director) Sale 20,000 37.56 751,140
2006-05-22 Prehn Mary E (Vice President-Licensing) Sale 30,281 38.59 1,168,604
2006-05-22 Prehn Mary E (Vice President-Licensing) Option Ex 55,260 21.09 1,165,212
2006-05-12 Goldwasser Dan L Sale 29,000 39.46 1,144,340
2006-05-11 Goldwasser Dan L Sale 16,000 40.10 641,552
2006-05-11 Goldwasser Dan L Option Ex 16,000 4.60 73,616
2006-04-26 Prehn Mary E (Vice President-Licensing) Option Ex 4,740 21.09 99,947
2006-03-16 Salans Lester B Sale 10,000 44.74 447,350
2006-03-16 Salans Lester B Option Ex 10,000 7.69 76,870
2006-03-15 Salans Lester B Sale 10,000 45.45 454,500
2006-03-15 Salans Lester B Option Ex 10,000 7.69 76,870
2006-02-27 Prehn Mary E (Vice President-Licensing) Sale 19,840 47.10 934,364
2006-01-25 Hochberg Elaine (Sr. VP, Marketing) Sale 68,728 44.02 3,025,544
2006-01-25 Hochberg Elaine (Sr. VP, Marketing) Option Ex 76,332 12.62 963,080
2006-01-18 Goldwasser Dan L Sale 26,000 42.69 1,110,018

Insider trading activities including stock purchases, stock sales, and option exercises of FRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Forest Laboratories Inc (symbol FRX, CIK number 38074) see the Securities and Exchange Commission (SEC) website.